Published: 2018-11-22

Articles

VALIDATION OF A PATIENT DECISION AID FOR CHOOSING BETWEEN DABIGATRAN AND WARFARIN FOR ATRIAL FIBRILLATION

Christina Hong, Shara Kim, Greg Curnew, Sam Schulman, Eleanor Pullenayegum, Anne Holbrook
Abstract 225 | PDF Downloads 132

THE RISE AND FALL OF THE THIAZOLIDINEDIONES: IMPACT OF CLINICAL EVIDENCE PUBLICATION AND FORMULARY CHANGE ON THE PRESCRIPTION INCIDENCE OF THIAZOLIDINEDIONES

Salman Hashim, Tara Gomes, David Juurlink, Chelsea Hellings, Muhammad Mamdani
Abstract 238 | PDF Downloads 134

Les Medicaments et la Sante Publique

sbryant sbryant
Abstract 162 | PDF Downloads 273

THERAPEUTIC DRUG MONITORING TO ASSESS CLINICAL RESPONSE TO SEDATIVE MEDICATIONS IN THE INTENSIVE CARE UNIT: A CASE REPORT AND DISCUSSION

Mahmoud Mosli, Daniel Ovakim, Rommel Tirona, George Dresser, Bandar Al-Judaibi
Abstract 172 | PDF Downloads 99

ODANACATIB DOES NOT INFLUENCE THE SINGLE DOSE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN

S Aubrey Stoch, Rose Witter, David Hreniuk, Chengcheng Liu, Stefan Zajic, Anish Mehta, Patricia Chandler, Denise Morris, Hongwei Xue, Andrew Denker, John A Wagner
Abstract 259 | PDF Downloads 81

PHARMACOKINETICS IN REAL LIFE: SEX AND GENDER DIFFERENCES

Donald R Mattison
Abstract 488 | PDF Downloads 659

IMPACT OF PREGNANCY ON PHARMACOKINETICS OF MEDICATIONS

Mary F Hebert
Abstract 1705 | PDF Downloads 913

GENDER BARRIERS IN POLICY AND REGULATION

Martha Nolan
Abstract 146 | PDF Downloads 86

CLINICAL PRACTICE GUIDELINE: CYP2D6 GENOTYPING FOR SAFE AND EFFICACIOUS CODEINE THERAPY

Parvaz Madadi, Ursula Amstutz, Michael Rieder, Shinya Ito, Vincent Fung, Soomi Hwang, Jacques Turgeon, Veronique Michaud, Gideon Koren, Bruce C Carleton
Abstract 1998 | PDF Downloads 647

MULTIPLE PRESCRIBERS IN OLDER FREQUENT OPIOID USERS – DOES IT MEAN ABUSE?

C Ineke Neutel, Svetlana Skurtveit, Christian Berg, Solveig Sakshaug
Abstract 205 | PDF Downloads 99

PERSONALIZED BENEFIT-HARM INFORMATION INFLUENCES PATIENT DECISIONS REGARDING WARFARIN

Anne M Holbrook, Eleanor M Pullenayegum, Sue M Troyan, Milica Nikitovic, Mark A Crowther
Abstract 165 | PDF Downloads 76

COMA, METABOLIC ACIDOSIS, AND METHEMOGLOBINEMIA IN A PATIENT WITH ACETAMINOPHEN TOXICITY

Hussein D Kanji, Shazma Mithani, Paul Boucher, Valerian C Dias, Mark C Yarema
Abstract 471 | PDF Downloads 267

SENSORY CONTROL OF BALANCE: A COMPARISON OF CHILDREN WITH FETAL ALCOHOL SPECTRUM DISORDERS TO CHILDREN WITH TYPICAL DEVELOPMENT

Tracy L Jirikowic, Sarah W McCoy, Anat Lubetzky-Vilnai, Robert Price, Marcia A Ciol, Deborah Kartin, Lin-Ya Hsu, Beth Gendler, Susan J Astley
Abstract 264 | PDF Downloads 85

CLINICAL CORRELATES OF FETAL ALCOHOL SPECTRUM DISORDER AMONG DIAGNOSED INDIVIDUALS IN A RURAL DIAGNOSTIC CLINIC

Mansfield Mela, Audrey McFarlane, Tolulope T Sajobi, Hasu Rajani
Abstract 418 | PDF Downloads 219

PHARMACOKINETICS OF ETHANOL IN THE MATERNAL-FETAL UNIT

Irene Zelner, Gideon Koren
Abstract 797 | PDF Downloads 572

ALCOHOL EXPOSURE AMONG PREGNANT WOMEN IN SUB-SAHARAN AFRICA: A SYSTEMATIC REVIEW

Celia L Culley, Tasha D Ramsey, Godfrey Mugyenyi, Gertrude N Kiwanuka, Joseph Ngonzi, Stuart MacLeod, Gideon Koren, Brian E Grunau, Matthew O Wiens
Abstract 768 | PDF Downloads 181

IDENTIFYING THE NEUROBEHAVIORAL PHENOTYPE OF FETAL ALCOHOL SPECTRUM DISORDER IN YOUNG CHILDREN

Petra Breiner, Irena Nulman, Gideon Koren
Abstract 711 | PDF Downloads 213